![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Varkaris Andreas Corn Paul G Gaur Sanchaika Dayyani Farshid Logothetis Christopher J Gallick Gary E
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.20, Iss.12, 2011-12, pp. : 1677-1684
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HGF/c-MET Targeted Therapeutics: Novel Strategies for Cancer Medicine
Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Development of c-MET pathway inhibitors
By Liu Xiangdong Newton Robert C Scherle Peggy A
Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. :